Foogie, they are preparing to go commercial. The only way to pay those bills is dilution. If you did not know that, that’s just the reality of a pre-revenue bio. They could sell out cheap if that’s what you’d prefer. They are taking it all the way. The fact that the stock is going down hard now, is not solely because of dilution. The same dilution has been happening on an ongoing basis. But they have a single product. It is pending approval. Some investors squeeze stocks at this point in time while others take money off the table in anticipation of that squeeze and until the decision, up or down, by the regulator is certain. So a lot of the current squeeze just happens normally to stocks at this stage. But the fact is there are people who accentuate such movements with nonstop bashing at these moments and we see that too, and they purpose is to keep potential buyers away. That’s a dynamic intended to squeeze things as far as they will go, so that when the news hits, they hope to be the first back in and can get in as cheaply as possible.
So we’re just witnessing a lot of swing trading s/it talking going on.
Market Data 
Markets 
AI
